12:00 AM
Feb 22, 2000
 |  BC Week In Review  |  Company News  |  Deals

Protein Design Labs, Fujisawa deal

PDLI will humanize an antibody selected by Fujisawa to treat inflammatory and immunologically mediated diseases. PDLI had previously modified...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >